Arsinothricin
| Clinical data | |
|---|---|
| Drug class | glutamine synthetase inhibitor |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| PDB ligand | |
| Chemical and physical data | |
| Formula | C5H12AsNO4 |
| Molar mass | 225.076 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Arsinothricin is a naturally occurring organoarsenical antibiotic produced by the rhizosphere bacterium Burkholderia gladioli. Structurally, it is a non-proteinogenic amino acid analog of glutamate, in which the γ-carboxyl group is replaced by a methylarsenate moiety. Arsinothricin acts as a broad-spectrum antibiotic effective against a variety of bacterial pathogens, including multidrug-resistant species, through competitive inhibition of bacterial glutamine synthetase. Unlike many arsenic compounds that are highly toxic due to their trivalent state, arsinothricin is unusual as a pentavalent arsenical, displaying antibiotic activity with a novel mechanism of action.